UniBio

Niigata, Japan

UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.

$3.2M raised

Feb 2024

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has UniBio raised?

UniBio has raised $3.2M in total funding. The most recent round was Series B. The last funding was announced in February 2024.

Who are UniBio's investors?

UniBio's investors include Niigata Venture Capital.

Where is UniBio headquartered?

UniBio is headquartered in Niigata, Japan.

What does UniBio do?

UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.

What stage is UniBio at?

UniBio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 29, 2024.

MLA

"UniBio — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/unibio. Accessed July 3, 2026.

APA

VCBacked. (2024). UniBio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/unibio

Wikipedia (cite web)

{{cite web |title=UniBio — Funding & Investors |url=https://www.vcbacked.co/company/unibio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 29, 2024.